A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract Surgery
Clinical trial NCT05550350 · WITHDRAWN
Trial details
- NCT number
- NCT05550350
- Sponsor
- EyePoint Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.